Sale!

MTTL2 Gene Encephalomyopathy Mitochondrial MTTL2 Related Genetic Test

Original price was: $700.Current price is: $500.

-29%

The MTTL2 Gene Encephalomyopathy Mitochondrial MTTL2 Related NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the MT-TL2 gene, which encodes mitochondrial tRNA for leucine. This specialized test helps diagnose mitochondrial encephalomyopathies, a group of rare neurological disorders affecting both the brain and muscles. Using Next-Generation Sequencing technology, the test provides comprehensive analysis of mitochondrial DNA mutations associated with conditions like mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). The test is priced at $500 USD and offers crucial insights for patients experiencing unexplained neurological symptoms, muscle weakness, developmental delays, or family history of mitochondrial disorders. Results typically take 3-4 weeks and require blood, extracted DNA, or blood spot samples.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

MTTL2 Gene Encephalomyopathy Mitochondrial MTTL2 Related NGS Genetic DNA Test

Understanding Mitochondrial Encephalomyopathy and the MT-TL2 Gene

Mitochondrial encephalomyopathies represent a complex group of inherited disorders that affect both the central nervous system and skeletal muscles. The MT-TL2 gene plays a critical role in mitochondrial function, encoding the mitochondrial tRNA for leucine, which is essential for protein synthesis within mitochondria. When mutations occur in this gene, they disrupt the mitochondrial energy production process, leading to severe neurological and muscular symptoms that can significantly impact quality of life.

What This Advanced Genetic Test Detects

Our comprehensive NGS Genetic DNA Test specifically targets mutations in the MT-TL2 gene using state-of-the-art Next-Generation Sequencing technology. This sophisticated approach enables us to:

  • Identify point mutations, deletions, and duplications in the MT-TL2 gene
  • Detect heteroplasmic mutations (mixed normal and mutant mitochondrial DNA)
  • Analyze mitochondrial DNA copy number variations
  • Provide detailed mutation load quantification
  • Screen for known pathogenic variants associated with mitochondrial disorders

Who Should Consider This Genetic Test?

Clinical Indications and Symptoms

This test is particularly recommended for individuals experiencing:

  • Unexplained neurological symptoms including seizures, stroke-like episodes, or developmental regression
  • Progressive muscle weakness, exercise intolerance, or fatigue
  • Elevated lactate levels in blood or cerebrospinal fluid
  • Vision or hearing problems of unknown origin
  • Family history of mitochondrial disorders or unexplained neurological conditions
  • Children with developmental delays, growth failure, or multiple organ involvement
  • Patients with suspected MELAS syndrome or related mitochondrial conditions

Significant Benefits of Early Genetic Testing

Undergoing the MTTL2 Gene Encephalomyopathy test provides numerous advantages:

  • Accurate Diagnosis: Obtain definitive answers for complex neurological symptoms
  • Personalized Treatment: Guide targeted therapeutic interventions and management strategies
  • Family Planning: Understand inheritance patterns and recurrence risks
  • Proactive Monitoring: Enable early intervention and symptom management
  • Clinical Trial Eligibility: Access to specialized treatments and research opportunities
  • Peace of Mind: Reduce diagnostic uncertainty and provide clear direction for care

Understanding Your Test Results

Our comprehensive genetic counseling support helps you interpret your results effectively:

  • Positive Result: Indicates the presence of pathogenic MT-TL2 mutations, confirming mitochondrial encephalomyopathy diagnosis
  • Negative Result: Suggests absence of tested MT-TL2 mutations, though other genetic causes may need investigation
  • Variant of Uncertain Significance: Identifies genetic changes with unclear clinical implications requiring further evaluation
  • Heteroplasmy Level: Quantifies the proportion of mutant mitochondrial DNA, helping predict disease severity

All results are accompanied by detailed explanations and recommendations from our certified genetic counselors.

Test Pricing and Details

Test Component Price (USD)
Discount Price $500
Regular Price $700
Turnaround Time 3-4 Weeks
Sample Type Blood, Extracted DNA, or Blood Spot on FTA Card

Nationwide Accessibility and Convenient Testing

GGC DNA maintains comprehensive testing facilities across the United States, with branches in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, and Philadelphia. Our network ensures that patients nationwide have access to this specialized genetic testing without the need for extensive travel.

Take the Next Step Toward Clarity

If you or your loved one is experiencing symptoms suggestive of mitochondrial encephalomyopathy, don’t delay in seeking answers. Our team of genetic specialists, neurologists, and certified counselors are ready to support you through every step of the testing process.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book the MTTL2 Gene Encephalomyopathy Mitochondrial DNA Test. Take control of your health journey with definitive genetic insights from GGC DNA.